查看購物車
  • Simplified Chinese
  • English
到 2030 年北美生物分析測試服務市場預測 - 區域分析 - 按服務分類；疾病適應症；和最終用戶
市場調查報告書
商品編碼
1463674

到 2030 年北美生物分析測試服務市場預測 - 區域分析 - 按服務分類；疾病適應症；和最終用戶

North America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User
出版日期: | 出版商: The Insight Partners | 英文 110 Pages | 訂單完成後即時交付

價格

2022年北美生物分析測試服務市值為17.9803億美元，預計2030年將達到39.7142億美元；預計2022年至2030年CAGR為10.4%。

製藥公司不斷增加的研發活動外包推動了北美生物分析測試服務市場

製藥公司將非其內部結構核心的研發活動外包。外包雜項活動使他們能夠有效地專注於其內部核心能力，從而使藥物開發過程更好、更具成本效益。此外，外包製造活動以及研發可以縮短週轉時間，增加他們的專業知識，並消除大量資本投資的需要，從而使他們受益。根據 BioPlan Associates 對生物製藥產能和生產的調查，分析測試/生物測定是 2022 年外包最多的服務，其次是毒性測試、驗證服務、產品表徵等。雖然發展中國家是透過合約製造對生物分析測試服務需求的最大貢獻者，但美國仍然是潛在的外包目的地。調查中 39.6% 的非美國受訪者更願意外包給美國設施。因此，外包的做法在全球範圍內越來越流行，特別是在發展中國家，從而有利於生物分析測試服務市場的成長。製藥公司正在廣泛實施品質源自於設計（QbD）概念，這進一步推動製藥公司採用外包服務，以提高其生產流程的穩健性，並確保最佳的產品品質和製造生產力。 QbD 得到美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構的支持。多年來，隨著 ICH Q9（品質風險管理）、ICH Q8（R2，藥品開發）和 ICH Q10（藥品品質系統）的發布，這一概念在製藥業獲得了廣泛關注。根據 ICH Q10 指南，分析方法對於藥品品質系統至關重要。在製造中實施分析 QbD (AQbD) 可確保產品品質和效能。外包生物分析測試服務可以幫助製藥公司避免對分析設備和熟練專業人員的大量投資，從而降低業務風險，特別是當產品處於開發的早期階段時。由於專業的分析測試服務提供者俱有快速提供優異結果的關鍵能力，製藥公司擴大考慮將生物分析測試服務外包給第三方服務供應商，這推動了市場的成長。

北美生物分析測試服務市場概況

北美佔據生物分析測試服務市場的最大佔有率，其中美國、加拿大和墨西哥是該地區市場成長的主要貢獻者。製藥業的不間斷成長、各種疾病發病率的上升對開發新藥的需求不斷增加、政府醫療保健支出的增加以及為保證藥品質量而對外包活動的日益偏好是有利的因素北美生物分析測試服務市場的成長。

北美生物分析測試服務市場收入及 2030 年預測（百萬美元）

北美生物分析測試服務市場細分

北美生物分析測試服務市場根據測試類型、疾病適應症、最終用戶和國家進行細分。

根據測試類型，北美生物分析測試服務市場分為藥物動力學、生物標記、免疫原性、病毒學測試、基於細胞的測定等。 2022 年，基於細胞的檢測領域佔據最大的市場佔有率。

根據疾病適應症，北美生物分析測試服務市場分為心血管、神經系統疾病、代謝失調、呼吸系統疾病、自體免疫疾病、腫瘤、性健康、骨骼疾病等。 2022 年，腫瘤學領域佔據最大的市場。

根據最終用戶，北美生物分析測試服務市場分為製藥和生物製藥公司、合約研究組織（CRO）、合約開發和製造組織（CDMO）等。 2022 年，製藥和生物製藥公司領域佔據最大的市場佔有率。

按國家/地區分類，北美生物分析測試服務市場分為美國、加拿大和墨西哥。 2022年，美國在北美生物分析測試服務市場佔有率中佔據主導地位。

SGS SA、康龍化成北京有限公司、Element Materials Technology Group Ltd、CD BioSciences Inc、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、KCAS Bioanalytical and Biomarker Services LLC、ICON Plc 和Intertek Group Plc 是北美生物分析測試服務市場上的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美生物分析測試服務市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

第 5 章：北美生物分析測試服務市場 - 主要產業動態

  • 主要市場促進因素：
    • 藥廠增加研發活動外包
    • 對生物相似藥和生物製劑分析測試的高需求
  • 主要市場限制：
    • 生物分析方法開發與驗證的挑戰
  • 主要市場機會
    • 醫藥產業持續成長
  • 未來的趨勢
    • 針對新興罕見疾病的藥物發現和開發活動不斷增加
  • 影響分析：

第 6 章：生物分析測試服務市場 - 北美市場分析

  • 生物分析測試服務市場收入，2022 - 2030

第 7 章：北美生物分析測試服務市場 - 收入和 2030 年預測 - 按服務

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按服務分類）（%）
  • 藥物動力學
  • 生物標記
  • 免疫原性
  • 病毒學檢測
  • 基於細胞的檢測
  • 其他

第 8 章：北美生物分析測試服務市場 - 2030 年收入和預測 - 按疾病適應症

  • 概述
  • 2022 年和 2030 年按疾病適應症分類的生物分析測試服務市場收入佔有率 (%)
  • 心血管
  • 神經系統疾病
  • 自體免疫疾病
  • 呼吸疾病
  • 代謝紊亂
  • 腫瘤學
  • 性健康
  • 骨病
  • 其他

第 9 章：北美生物分析測試服務市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按最終用戶分類）（%）
  • 製藥和生物製藥公司
  • 合約研究組織（CRO）
  • 合約開發與製造組織 (CDMO)
  • 其他

第 10 章：北美生物分析測試服務市場 - 國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 11 章：生物分析測試服務市場產業格局

  • 概述
  • 生物分析測試服務市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • CD BioSciences Inc
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc

第 13 章：附錄

Product Code: BMIRE00029563

The North America bioanalytical testing services market was valued at US$ 1,798.03 million in 2022 and is expected to reach US$ 3,971.42 million by 2030; it is estimated to grow at a CAGR of 10.4% from 2022 to 2030.

Increasing Outsourcing of R&D Activities by Pharmaceutical Companies fuel the North America Bioanalytical Testing Services Market

Pharmaceutical companies outsource research & development activities that are not core to their internal structure. Outsourcing miscellaneous activities allows them to efficiently focus on their internal core competencies for making the drug development process better and more cost effective. Moreover, outsourcing manufacturing activities, along with R&D, benefits them by lowering the turnaround period, adding to their expertise, and eliminating the need for large capital investments. According to the Survey of Biopharmaceutical Manufacturing Capacity and Production by BioPlan Associates, analytical testing/bioassay was the most outsourced service in 2022, followed by toxicity testing, validation services, product characterization, and others. While developing nations are the largest contributors to the demand for bioanalytical testing services through contract manufacturing, the US remains a potential outsourcing destination. 39.6% of non-US respondents in the survey preferred outsourcing to US-based facilities. Thus, the practice of outsourcing is gaining popularity worldwide, especially in developing countries, thereby favoring the growth of the bioanalytical testing services market. Pharmaceutical businesses are widely implementing the quality-by-design (QbD) concept, which is further propelling the adoption of outsourcing services by pharmaceutical companies to increase the robustness of their production processes and ensure optimal product quality and manufacturing productivity. QbD is supported by regulatory bodies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The concept has gained traction in the pharmaceutical industry over the years with the publication of ICH Q9 (Quality Risk Management), ICH Q8 (R2, Pharmaceutical Development), and ICH Q10 (Pharmaceutical Quality System). According to the ICH Q10 guidelines, analytical methods are essential to the pharmaceutical quality system. Analytical QbD (AQbD) implementation in manufacturing ensures product quality and performance. Outsourcing bioanalytical testing services helps pharmaceutical businesses reduce business risks by avoiding major investments in analytical equipment and skilled professionals, especially while the product is in the early phase of development. Due to the availability of specialized analytical testing service providers with crucial competencies to quickly provide excellent results, pharmaceutical companies are increasingly considering outsourcing bioanalytical testing services to third-party service providers, which fuels the market growth.

North America Bioanalytical Testing Services Market Overview

North America holds the largest share of the bioanalytical testing services market, with the US, Canada, and Mexico being the major contributors to the market growth in this region. The uninterrupted growth of the pharmaceuticals industry, the increasing need for developing novel drugs due to an upsurge in the incidences of various diseases, rising healthcare expenditure by governments, and a growing preference for outsourcing activities for the quality assurance of pharmaceutical products are the factors favoring the growth of the bioanalytical testing services market in North America.

North America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

North America Bioanalytical Testing Services Market Segmentation

The North America bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the North America bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the North America bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the North America bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the North America bioanalytical testing services market is segmented into the US, Canada, and Mexico. The US dominated the North America bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, CD BioSciences Inc, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, KCAS Bioanalytical and Biomarker Services LLC, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the North America bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. North America Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - North America Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
      • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 In-Vivo Virology Testing
      • 7.6.3.1 Overview
      • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Respiratory Diseases
    • 8.6.1 Overview
    • 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Metabolic Disorders
    • 8.7.1 Overview
    • 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Oncology
    • 8.8.1 Overview
    • 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Sexual Health
    • 8.9.1 Overview
    • 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Bone Disease
    • 8.10.1 Overview
    • 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development and Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Bioanalytical Testing Services Market - Country Analysis

  • 10.1 North America Bioanalytical Testing Services Market, Revenue And Forecast To 2030
    • 10.1.1 Overview
      • 10.1.1.1 North America Bioanalytical Testing Services Market, by Country
      • 10.1.1.2 US
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 US Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 US Bioanalytical Testing Services Market, by Services
        • 10.1.1.2.3.1 US Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.2.4 US Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.2.5 US Bioanalytical Testing Services Market, by End User
      • 10.1.1.3 Canada
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Canada Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Canada Bioanalytical Testing Services Market, by Services
        • 10.1.1.3.3.1 Canada Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.3.4 Canada Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.3.5 Canada Bioanalytical Testing Services Market, by End User
      • 10.1.1.4 Mexico
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Mexico Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Mexico Bioanalytical Testing Services Market, by Services
        • 10.1.1.4.3.1 Mexico Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.4.4 Mexico Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.4.5 Mexico Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 SGS SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pharmaron Beijing Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Element Materials Technology Group Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 CD BioSciences Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Charles River Laboratories International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eurofins Scientific SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Labcorp Drug Development Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Syneos Health Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 KCAS Bioanalytical and Biomarker Services LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 ICON Plc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Intertek Group Plc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Bioanalytical Testing Services Market Segmentation
  • Table 2. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 3. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 5. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 6. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 15. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 16. Glossary of Terms, North America Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. North America Bioanalytical Testing Services Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. North America Bioanalytical Testing Services Market, by Country - Revenue 2022 ($Mn)
  • Figure 31. North America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 32. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Growth Strategies in the Bioanalytical Testing Services Market